Department of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Department of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan.
Int J Mol Sci. 2019 Feb 22;20(4):957. doi: 10.3390/ijms20040957.
Substantial improvements in cancer treatment have resulted in longer survival and increased quality of life in cancer survivors with minimized long-term toxicity. However, infertility and gonadal dysfunction continue to be recognized as adverse effects of anticancer therapy. In particular, alkylating agents and irradiation induce testicular damage that results in prolonged azoospermia. Although damage to and recovery of spermatogenesis after cancer treatment have been extensively studied, there is little information regarding the role of differences in testicular immunology in cancer treatment-induced male infertility. In this review, we briefly summarize available rodent and human data on immunological differences in chemotherapy or radiotherapy.
癌症治疗的显著进展使癌症幸存者的生存时间延长,生活质量提高,同时长期毒性也降到最低。然而,不孕和性腺功能障碍仍然被认为是抗癌治疗的副作用。特别是烷化剂和放疗会导致睾丸损伤,从而导致长期无精子症。虽然癌症治疗后精子发生的损伤和恢复已经得到了广泛的研究,但关于睾丸免疫学在癌症治疗引起的男性不育中的作用的信息却很少。在这篇综述中,我们简要总结了现有关于化疗或放疗中免疫差异的啮齿动物和人类数据。